Latest filing published 15 Sept 2026 for Clover Health Investments, CORP. /de, €28k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Karen Soares (senior executive) discloses dealings in Clover Health Investments, CORP. /de to SEC (Form 4). In total, 39 filings cover trades dated from 31 October 2023 to 15 September 2026.
Sales make up the whole of the open-market record (5 sales, €460k). No amount is published for 1 filing, which the totals therefore leave out. The rest of the record consists of 34 share grants. 2026 to date brings no purchases and 4 sales.
The newest entry dates from 15 September 2026: an open-market sale of €28k, in Clover Health Investments, CORP. /de. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 39 declarations